← Top stories
Deal▲ Bullish for Gland Pharma
Gland Pharma to invest $21 million in US drugmaker, take 60% stake
The brief
- Gland Pharma will invest $21 million in its US subsidiary
- The subsidiary will acquire a 60% stake in newly incorporated Novelstar Pharma
- The investment expands Gland Pharma’s US business, giving investors a new overseas growth initiative to track